A detailed history of Blackhawk Capital Partners Llc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Blackhawk Capital Partners Llc. holds 2,176 shares of BIO stock, worth $768,367. This represents 0.38% of its overall portfolio holdings.

Number of Shares
2,176
Previous 749 190.52%
Holding current value
$768,367
Previous $250,000 185.6%
% of portfolio
0.38%
Previous 0.14%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 04, 2025

BUY
$313.15 - $374.28 $446,865 - $534,097
1,427 Added 190.52%
2,176 $714,000
Q3 2024

Nov 12, 2024

BUY
$263.97 - $344.64 $197,713 - $258,135
749 New
749 $250,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.7B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Blackhawk Capital Partners Llc. Portfolio

Follow Blackhawk Capital Partners Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blackhawk Capital Partners Llc., based on Form 13F filings with the SEC.

News

Stay updated on Blackhawk Capital Partners Llc. with notifications on news.